この記事を読む

ICI治療、腺癌での肺臓炎発症は高リスク?

Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy. Sure…

この記事を読む

診断後の禁煙の有用性

Longitudinal study to assess impact of smoking at diagnosis and quitting on 1-year survival for people with non-small ce…

この記事を読む

KEYNOTE-024 最新の生存データ

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cance…

この記事を読む

心身障碍者の肺癌、わずかに高い死亡率だが…

Disparities in the Diagnosis and Treatment of Lung Can∺er among People with Disabilities. Shin DW et al. J Thorac Oncol.…

この記事を読む

再発小細胞肺癌に対するニボルマブの効果

Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032. Ready N et al. J Thorac Oncol. 2019 Feb;14(2):237-244…

この記事を読む

胸腺腫瘍に対するペムブロリズマブ

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial. Cho J et a…

この記事を読む

腫瘍全体におけるマイクロサテライト不安定性とリンチ症候群

Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. Latham A et al. J Clin Oncol. 2…

この記事を読む

アテゾリズマブにbeyond PD効果はあるか

Atezolizumab Treatment Beyond Progression in Advanced NSCLC: Results From the Randomized, Phase III OAK Study. Gandara D…

この記事を読む

免疫療法の性差のその後

Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Sys…

この記事を読む

中枢型肺腺癌では骨転移が多く予後不良

New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter coh…